In short. Approval attaches to a product and a stated purpose, not to a technique. What it means to be offered a mixture that has never been assessed as a mixture.
Key points
- A named clinician who can list the substances, an institution that holds the plan to its own standards, and a written record you can keep.
- Those three are what a patient can actually check, and where none of them is available, nothing else about the offer is testable either.
Approval is not a quality mark awarded to treatments in general. It attaches to a specific product, made to a specification, assessed for a stated purpose, with a defined way of being used. Understanding that shape explains most of what is confusing about the regulation of this subject, because mesotherapy is a method and a method is not something a regulator can approve.
What approval actually covers
A licensed injectable is licensed as itself and for a named use. It may also be used outside that use by a clinician exercising judgement, which is lawful in many places and is a decision taken with the patient rather than for them. What the licence does not do is travel. Once substances are combined, the assessment behind each one describes that substance alone, at its own specification, and says nothing about what happens when several are mixed and placed into the face together.
Where a prepared mixture sits
Many plans combine products, or prepare a mixture for the occasion. Compounding is a normal part of medicine and has its own rules, and it exists because a standard product does not fit every case. The honest description of the regulatory position here is not that the mixture is banned or that it is approved, but that it has not been assessed as a mixture, and that something else has to stand in for that assessment. Usually what stands in is the judgement of the clinician and the standards of the institution.
What is a reasonable substitute for an assessment
A named clinician who can list the substances, an institution that holds the plan to its own standards, and a written record you can keep. Those three are what a patient can actually check, and where none of them is available, nothing else about the offer is testable either.
Why this is a patient question rather than a legal one
Whether a particular plan is permitted is a question for regulators and lawyers, and it varies by place. Whether it has been assessed is a question you can ask, and the answer is usually straightforward. Those are different questions, and a clinic that answers the second by appealing to the first has moved the conversation somewhere you cannot check. What you can check is the list, the record and who is accountable for it. Ask for those three, and if the reply is a description of the technique, that is your answer. None of that requires legal training, only the willingness to ask twice.
These answers should make you pause
- That the mixture is approved because its ingredients are approved.
- That regulatory questions are too technical for a patient to ask.
- That nothing can be put in writing because the formula is proprietary.
What the study record behind a mixture looks like is set out in What the Evidence Supports, and the questions that expose an unstandardised product are in Judging a Provider.
Frequently asked questions
Is a compounded mixture illegal?
Usually not, and that is not the point. Compounding exists for good reasons and has its own rules in most places. The question a patient should be asking is narrower: whether the particular mixture has been assessed as a mixture for the use proposed, and where the answer is no, what is standing in for that assessment.
Does a licensed ingredient make the mixture licensed?
No. The licence attaches to the product and to the purpose it was assessed for. Once substances are combined and used for something else, the licence of each part does not follow into the syringe, and no regulator has looked at the combination as a whole.
What should be written in my record if I go ahead?
The substances, the areas treated, the date and the treating clinician, and for anything that arrived as a licensed product the product details. Ask for that at the end of every session. Where the contents cannot be written down, nothing can be reviewed later, including by you.
Risks & Limitations
- Mesotherapy names a technique, not a product. The mixture is often prepared rather than manufactured, and it has not been assessed as a mixture.
- Any change reported is usually modest, lies in surface quality rather than in volume, and fades without further sessions.
- Firm lumps and delayed reactions can appear weeks to months after a session, and the date they appear is part of how they are assessed.
- A mixture is not standardised between clinics or between sessions, so the evidence for one plan says nothing about the next.
When to Seek Care
- Severe pain out of proportion to the procedure, or skin turning white, grey, mottled or dusky, needs immediate assessment.
- Any change in vision after an injection requires emergency care.
- Fever, or redness, warmth or discharge at a treated area that is spreading rather than settling.
- A firm lump or nodule appearing weeks or months later, which should be reported when noticed rather than at a review.
References & Further Reading
- American Society of Plastic Surgeons (ASPS) — procedure and safety guidance
- National Institute for Health and Care Excellence (NICE, UK) — relevant guidance
- Cochrane Library — systematic reviews
- Chinese Medical Association Plastic Surgery Branch — clinical guidance
This page is patient education, not medical advice, and it does not cite individual studies. Discuss your own case with a qualified clinician. To arrange an assessment at Chongqing West District Hospital, see Contact & Consultation.